W.G. Shaheen & Associates Dba Whitney & CO Bausch Health Companies Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$17.64 - $28.32 $15,876 - $25,488	-900 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $18,576 - $23,103	900 New	900 $25,000

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$294 Million
2.88% of portfolio
Goldentree Asset Management LP New York, NY

29.4M
Shares

$249 Million
21.8% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$224 Million
14.7% of portfolio
National Bank Of Canada

15.6M
Shares

$133 Million
0.18% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$110 Million
0.26% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account